Stichworte: euro adhoc Channel: Finanzen
OTE0006   21. Nov. 2011, 17:03

EANS-Voting Rights: Marseille-Kliniken AG / Release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution


Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement.

Announcement according to Article 21, Section 1 of the WpHG (share)

1. DL Verwaltungs GmbH & Co. WP KG, Zirchow, Germany, has informed us on 17 November 2011 according to sec. 21, para. 1 of the WpHG that their share of voting rights in Marseille-Kliniken AG has exceeded the thresholds of 3%, 5%, 10%, 15%, 20%, 25% and 30% on 04 November 2011 and has amounted to 32.42% on this day. This is equivalent to 4,726,629 directly held voting rights of the overall 14,580,000 voting rights in Marseille-Kliniken AG.

2. DL-Holding GmbH, Zirchow, Germany, has informed us on 17 November 2011 according to sec. 21, para. 1 of the WpHG that their share of voting rights in Marseille-Kliniken AG has exceeded the thresholds of 3%, 5%, 10%, 15%, 20%, 25% and 30% on 04 November 2011 and has amounted to 32.42% on this day. This is equivalent to 4,726,629 attributed voting rights of the overall 14,580,000 voting rights in Marseille-Kliniken AG.

Of these voting rights, 32.42% (4,726,629 voting rights) are attributed to DL-Holding GmbH pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG in connection with sec. 22 para. 3 WpHG from DL Verwaltungs GmbH & Co. WP KG, which is a subsidiary of DL-Holding GmbH.

end of announcement   euro adhoc

 issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:        info@marseille-kliniken.de
WWW:         http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Stuttgart, Düsseldorf, regulated dealing: Hamburg 
language:    English
Vergrößern

OTS-Originaltext Presseaussendung unter ausschließlicher inhaltlicher Verantwortung des Aussenders.
OTE0006 2011-11-21 17:03 211703 Nov 11 EAE0002 0315



Marseille-Kliniken AG Zur Pressemappe

Rückfragehinweis: Contact Marseille-Kliniken AG:
Andreas Sielemann
General Representative
Sportallee 1
22335 Hamburg
Germany
Tel.: +49-(0)40-51459-0
www.marseille-kliniken.com

Aussendungen von Marseille-Kliniken AG abonnieren: als RSS-Feed per Mail


Errechnete Tags: